Nature Communications (Oct 2016)
Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1
Abstract
Midbrain dopaminergic neurons generated from stem cells show promise for the treatment of Parkinson’s disease. Here, the authors use the cell surface marker, LRTM1, to enrich the midbrain dopaminergic progenitors and show improved motor function/cell survival when grafted into rat/monkey brains, respectively.